Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons

Journal of Neuroscience Research

Volumn 69, Issue 6, 2002, Pages 955-965

  Ostenfeld, Thor ^a   Tai, Yu Tzu ^a   Martin, Peter ^b   Déglon, Nicole ^b   Aebischer, Patrick ^b   Svendsen, Clive N ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

6 OHDA; Neural stem cells; Neurospheres; Parkinson's disease

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DNA MODIFICATION; DOPAMINERGIC NERVE CELL; DOWN REGULATION; EMBRYO; FEMALE; GENE CONSTRUCT; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL DEGENERATION; NERVE FIBER GROWTH; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; STEM CELL TRANSPLANTATION;

ANIMALS; ASTROCYTES; BEHAVIOR, ANIMAL; CELL SURVIVAL; CELLS, CULTURED; DENERVATION; DISEASE MODELS, ANIMAL; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; INDICATORS AND REAGENTS; LENTIVIRUS; LUMINESCENT PROTEINS; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURITES; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; STEM CELLS; SYMPATHOLYTICS;

EID: 0037106092     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10396     Document Type: Article

References (67)

1. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease
2. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells
3. Trophic interactions between astroglial cells and hippocampal neurons in culture
4. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum
5. Lentiviral vectors as a gene delivery system in the mouse midbrain: Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF
6. The use of neural stem cells for gene therapy in the central nervous system
7. Studies on neuroprotective and regenerative effcts of GDNF in a partial lesion model of Parkinson's disease
8. Defective glia in the Drosophila brain degeneration mutant drop-dead
9. Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture
10. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice
11. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming reactive astrocytes in adult transgenic mice
12. Development and survival of rat embryonic mesencephalic dopaminergic neurones in serum-free, antioxidant-rich primary cultures
13. GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro
14. Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease
15. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease
16. Gene transfer into neurons from hippocampal slices: Comparison of recombinant Semliki Forest virus, adenovirus, adeno-associated virus, lentivirus, and measles virus
17. Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts
18. Neural precursor cells: Applications for the study and repair of the central nervous system
19. Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain
20. Intraparenchymal putaminal infusion of glial derived neurotrophic factor in the treatment of advanced Parkinson's disease
21. Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus
22. Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo
23. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor
24. Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease
25. Method for serum-free culture of late fetal and early postnatal rat brainstem neurons
26. Lentiviral gene transfer to the nonhuman primate brain
27. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
28. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
29. Programmed cell death in developing grafts of fetal substantia nigra
30. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue
31. Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor
32. Development of a self-inactivating lentivirus vector
33. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
34. Mouse epidermal growth factor-responsive neural precursor cells increase the survival and functional capacity of embryonic rat dopamine neurons in vitro
35. Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation
36. Regional specification of rodent and human neurospheres
37. Neural stem cells-a versatile tool for cell replacement and gene therapy in the central nervous system
38. Gene expression in astrocytes is affected by subculture
39. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts
40. Glial cell linederived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts
41. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model
42. Inducible gene expression in mammalian cells and transgenic mice
43. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts
44. GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts
45. Immature type-1 astrocytes suppress glial scar formation, are motile and interact with blood vessels
46. Transplantation of immature and mature astrocytes and their effect on scar formation in the lesioned central nervous system
47. Changing role of forebrain astrocytes during development, regenerative failure, and induced regeneration upon transplantation
48. Maturation of astrocytes in vitro alters the extent and molecular basis of neurite outgrowth
49. Modulation of adhesion molecule expression on rat cortical astrocytes during maturation
50. Multipotent neural progenitor or stem-like cells may be uniquely suited for therapy for some neurodegenerative conditions
51. Differentiation of adult hippocampus-derived progenitors into olfactory neurons in vivo
52. Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease
53. Increased survival of rat EGF-generated CNS precursor cells using B27 supplemented medium
54. Survival and differentiation of rat and human epidermal growth factor-responsive precursor cells following grafting into the lesioned adult central nervous system
55. Restricted growth potential of rat neural precursors as compared to mouse
56. Human neural stem cells: Isolation, expansion and transplantation
57. Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer
58. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease
59. Metabolic coupling between glia and neurons
60. Incorporation and glial differentiation of mouse EGF-responsive neural progenitor cells after transplantation into the embryonic rat brain
61. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue
62. Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease
63. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats
64. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
65. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
66. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors